We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Argent Biopharma Limited | LSE:RGT | London | Ordinary Share | AU0000326647 | ORD NPV (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 6.00 | 5.00 | 7.00 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
Hot Features
Premium
RNS Number:0969M
ReGen Therapeutics PLC
10 June 2003
REGEN THERAPEUTICS PLC
Results of Annual General Meeting
10th June 2003
ReGen Therapeutics Plc (the "Company") announces that at the Annual General
Meeting of the Company held earlier today the Company's shareholders passed all
of the resolutions proposed, as detailed in the notice of annual general meeting
sent to shareholders dated 15 May 2003.
For further information please contact:
Andrew Marshall
Marshall Robinson Roe
Tel No 020 7489 2033
This information is provided by RNS
The company news service from the London Stock Exchange
END
RAGUKOVRONRNRAR
1 Year Argent Biopharma Chart |
1 Month Argent Biopharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
